IL-5 antibody, antigen binding fragment thereof, and medical application therefor
US12258394B2 · kind B2 · utility
0Cited by
2References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 18, 2022 |
| Grant date | Mar 25, 2025 |
| Priority date | — |
| Expiry date | Feb 22, 2043 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/5409
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are an IL-5 antibody, an antigen binding fragment thereof, and a medical application therefor. The present invention comprises a mouse-derived antibody containing an IL-5 antibody CDR region, a chimeric antibody, a humanized antibody, and a pharmaceutical composition comprising said IL-5 antibody and said antigen binding fragment thereof, as well as the use of the pharmaceutical composition as a drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.